MedTrace Logo

Fecal Microbiota Transplantation for Health Improvement (TFM3)

NCT04011943 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-07-09

No results posted yet for this study

Summary

Search for mechanisms of the effect of fecal transplantation on a healthy organism and various nosological forms.

Conditions

Interventions

OTHER

Fecal Microbiota Transplantation

Fecal Microbiota Transplantation

Sponsors & Collaborators

  • Federal Research and Clinical Center of Physical-Chemical Medicine

    lead OTHER

Principal Investigators

  • Elena Ilina, MD · FRCC PCM

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-21
Primary Completion
2020-12-01
Completion
2020-12-01

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04011943 on ClinicalTrials.gov